Jazz Pharmaceuticals

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Jazz Pharmaceuticals (JAZZ), The Latest Update Raises A Bigger Question (öffnet in neuem Tab)

  Simply Wall Street · 02.10.2026

• After a $1.5M September sale, Jazz Pharmaceuticals (NASDAQ: JAZZ) officer proposes another. (öffnet in neuem Tab)

  Stock Titan · 01.10.2026

• Q2 Earnings Outperformers: Jazz Pharmaceuticals (NASDAQ:JAZZ) And The Rest Of The Pharmaceuticals Stocks (öffnet in neuem Tab)

  Yahoo Finance · 30.09.2026

• Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE) (öffnet in neuem Tab)

  Seeking Alpha · 30.09.2026

• Jazz Pharmaceuticals Initiated at Buy by Citigroup (öffnet in neuem Tab)

  Moomoo · 30.09.2026

• Jazz Pharmaceuticals initiated with a Buy at Citi (öffnet in neuem Tab)

  tipranks.com · 30.09.2026

• Citigroup Initiates Jazz Pharmaceuticals at Buy With $325 Price Target (öffnet in neuem Tab)

  marketscreener.com · 30.09.2026

• Jazz Pharmaceuticals stock falls 2.43 percent as guidance rises (öffnet in neuem Tab)

  AD HOC NEWS · 29.09.2026

• What Comes Next for Jazz Pharmaceuticals (NASDAQ:JAZZ)? (öffnet in neuem Tab)

  Kalkine Media · 28.09.2026

• Jazz Pharmaceuticals stock reports record Q2 revenue growth (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026

• Goldman Sachs initiates Jazz Pharmaceuticals stock with buy rating By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 24.09.2026

• Jazz Pharmaceuticals PLC (J7Z.HA) Analyst insights, Price targets and Recommendations (öffnet in neuem Tab)

  Yahoo Finance UK · 24.09.2026

• Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026 (öffnet in neuem Tab)

  TradingView · 23.09.2026

• Jazz Pharmaceuticals Extends And Reprices $1.895 Billion Term Loan B To 2033 (öffnet in neuem Tab)

  TradingView · 23.09.2026

• Five more years to repay its loans: Jazz Pharmaceuticals (JAZZ) also lowers borrowing margins. (öffnet in neuem Tab)

  Stock Titan · 23.09.2026

• Jazz Pharmaceuticals (JAZZ) Gains Put Its Valuation Story Back In Focus (öffnet in neuem Tab)

  Simply Wall Street · 23.09.2026

• Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B (öffnet in neuem Tab)

  Yahoo Finance · 20.09.2026

• Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands (öffnet in neuem Tab)

  Yahoo Finance · 20.09.2026

• Ajit Baid Joins Jazz Pharmaceuticals as Executive Director, Head of Marketing – EMD Franchise (öffnet in neuem Tab)

  hrtoday.in · 18.09.2026

• Should You Buy Jazz Pharmaceuticals Stock After Its Actio Acquisition? (öffnet in neuem Tab)

  Yahoo Finance · 18.09.2026

• Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet (öffnet in neuem Tab)

  Yahoo Finance · 17.09.2026

• Jazz Pharmaceuticals at Deutsche Bank 2026 Healthcare Summit: ziihera drives growth (öffnet in neuem Tab)

  Investing.com · 16.09.2026

• Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences (öffnet in neuem Tab)

  PR Newswire · 15.09.2026

• Jazz Pharmaceuticals acquires Actio Biosciences for $820M (September 2026) (öffnet in neuem Tab)

  Dealroom · 15.09.2026

• Jazz Pharmaceuticals Completes $820 Million Upfront Acquisition of Actio Biosciences (öffnet in neuem Tab)

  Yahoo Finance · 15.09.2026

• Jazz Pharmaceuticals (JAZZ) Eyes Ziihera Trials In Breast Colorectal And Lung Cancer (öffnet in neuem Tab)

  Yahoo Finance · 14.09.2026

• 2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead (öffnet in neuem Tab)

  Yahoo Finance · 11.09.2026

• Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says (öffnet in neuem Tab)

  Yahoo Finance · 11.09.2026

• UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating (öffnet in neuem Tab)

  Yahoo Finance · 11.09.2026

• UBS raises Jazz Pharmaceuticals stock price target on Ziihera approval By Investing.com (öffnet in neuem Tab)

  Investing.com UK · 11.09.2026